全文获取类型
收费全文 | 5138篇 |
免费 | 492篇 |
国内免费 | 75篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 135篇 |
妇产科学 | 111篇 |
基础医学 | 590篇 |
口腔科学 | 94篇 |
临床医学 | 495篇 |
内科学 | 1017篇 |
皮肤病学 | 68篇 |
神经病学 | 252篇 |
特种医学 | 379篇 |
外科学 | 701篇 |
综合类 | 190篇 |
预防医学 | 471篇 |
眼科学 | 190篇 |
药学 | 407篇 |
中国医学 | 96篇 |
肿瘤学 | 476篇 |
出版年
2023年 | 44篇 |
2022年 | 59篇 |
2021年 | 104篇 |
2020年 | 67篇 |
2019年 | 111篇 |
2018年 | 103篇 |
2017年 | 93篇 |
2016年 | 93篇 |
2015年 | 135篇 |
2014年 | 163篇 |
2013年 | 196篇 |
2012年 | 269篇 |
2011年 | 270篇 |
2010年 | 188篇 |
2009年 | 187篇 |
2008年 | 271篇 |
2007年 | 293篇 |
2006年 | 244篇 |
2005年 | 280篇 |
2004年 | 209篇 |
2003年 | 215篇 |
2002年 | 170篇 |
2001年 | 136篇 |
2000年 | 126篇 |
1999年 | 136篇 |
1998年 | 100篇 |
1997年 | 96篇 |
1996年 | 84篇 |
1995年 | 79篇 |
1994年 | 64篇 |
1993年 | 63篇 |
1992年 | 100篇 |
1991年 | 90篇 |
1990年 | 84篇 |
1989年 | 97篇 |
1988年 | 97篇 |
1987年 | 92篇 |
1986年 | 62篇 |
1985年 | 61篇 |
1984年 | 37篇 |
1983年 | 33篇 |
1982年 | 41篇 |
1981年 | 35篇 |
1980年 | 29篇 |
1979年 | 29篇 |
1978年 | 20篇 |
1977年 | 23篇 |
1976年 | 27篇 |
1975年 | 15篇 |
1972年 | 12篇 |
排序方式: 共有5705条查询结果,搜索用时 15 毫秒
121.
122.
123.
124.
Geographic differences in manifestation of psoriatic arthritis (PsA) could be related to differences in genetic or environmental factors. We aimed to compare the disease activity and functional status using validated outcome measures among patients with PsA of different ethnicities living in the same environment. We performed a cross-sectional study on consecutive patients with PsA classified by the Classification Criteria for Psoriatic Arthritis (CASPAR) criteria from a single center. Sociodemographic data, clinical variables, and patient-reported outcomes were collected using a standardized protocol. Disease activities were assessed by validated composite scores: clinical Disease Activity Index for Psoriatic Arthritis (cDAPSA), Composite Psoriatic Disease Activity Index (CPDAI), and minimal disease activity (MDA). Physical function was assessed with Health Assessment Questionnaire (HAQ) and the Medical Outcome Study Short-Form 36 (SF36) physical function subscales. Linear regression analyses were performed to identify variables associated with disease activities and physical function. Ninety-eight patients (51.5%, men) with mean (±SD) age and duration of PsA of 51.5 ± 13.8 and 5.5 ± 8.4 years were recruited. Indian was overrepresented compared with the national distribution of ethnicities. Compared to Chinese, Indian patients were more likely to be using biological therapies, have higher tender joint count, and worse enthesitis. Higher proportion of Indians had higher disease activity categories measured by cDAPSA, CPDAI, and MDA and had poorer physical function. In the multivariable analysis, ethnicity was significantly associated with HAQ and SF36-PF. Compared to Chinese, Indians with PsA living in the same environment had worse disease activity and physical function measured by validated outcomes. 相似文献
125.
126.
127.
V. Sawlani N. Davies M. Patel R. Flintham C. Fong G. Heyes G. Cruickshank N. Steven A. Peet A. Hartley H. Benghiat S. Meade P. Sanghera 《Clinical oncology (Royal College of Radiologists (Great Britain))》2019,31(1):41-49
Aims
Following stereotactic radiosurgery (SRS), brain metastases initially increase in size in up to a third of cases, suggesting treatment failure. Current imaging using structural magnetic resonance imaging (MRI) cannot differentiate between tumour recurrence and SRS-induced changes, creating difficulties with patient management. Combining multiparametric MRI techniques, which assess tissue physiological and metabolic information, has shown promise in answering this clinical question.Materials and methods
Multiparametric MRI techniques, including spectroscopy, diffusion and perfusion imaging, were used for the differentiation of radiation-related changes and tumour recurrence after SRS for intracranial metastases in six cases. All patients presented with enlargement of the treated lesion, an increase in perilesional brain oedema and aggravation or appearance of neurological signs and symptoms from 7 to 29 weeks after primary treatment.Results
Multiparametric imaging helped to differentiate features of tumour progression (n = 4) from radiation-related changes (n = 2). A low apparent diffusion coefficient (ADC) <1000 × 10?6 mm2/s, high relative cerebral blood volume (rCBV) ratio > 2.1, high choline:creatine (Cho:Cr) ratio > 1.8 suggested tumour recurrence. A high ADC > 1000 × 10?6 mm2/s, low rCBV ratio < 2.1, Cho:Cr ratio < 1.8 suggested SRS-induced radiation changes. Multiparametric MRI diagnosis was confirmed by histology or radiological and clinical follow-up.Conclusion
Multiparametric MRI was helpful in the early identification of radiation-related changes and tumour recurrence and may be useful for monitoring treatment changes in intracranial neoplasms after SRS treatment. 相似文献128.
Jing Qi Yuman Fong Leonard Saltz Michael I. D'Angelica Nancy E. Kemeny Mithat Gonen Jinru Shia Amita Shukla‐Dave William M. Jarnagin Richard K. G. Do Lawrence H. Schwartz Jason A. Koutcher Kristen L. Zakian 《NMR in biomedicine》2013,26(2):204-212
Hepatic steatosis is a hallmark of chemotherapy‐induced liver injury. We made serial 1H MRS measurements of hepatic lipids in patients over the time course of a 24‐week chemotherapeutic regimen to determine whether 1H MRS could be used to monitor the progression of chemotherapy‐induced steatosis. Thirty‐four patients with stage III or IV colorectal cancer receiving 5‐fluorouracil, folinic acid and oxaliplatin (n = 21) or hepatic arterial infusion of floxuridine with systemic irinotecan (n = 13) were studied prospectively. 1H MRS studies were performed at baseline and after 6 and 24 weeks of treatment. A 1H MR spectrum was acquired from the liver during a breath hold and the ratio of fat to fat + water (FFW) was calculated to give a measure of hepatic triglycerides (HTGCs). The methodology was histologically validated in 18 patients and the reproducibility was assessed in 16 normal volunteers. Twenty‐seven patients completed baseline, 6‐week and 24‐week 1H MRS examinations and one was censored. Thirteen of 26 patients (50%) showed an increase in FFW after completion of treatment. Six patients (23%) developed hepatic steatosis and two patients converted from steatosis to nonsteatotic liver. Patients whose 6‐week hepatic lipid levels had increased significantly relative to baseline also had a high probability of lipid elevation relative to baseline at the completion of treatment. Serial 1H MRS is effective for the monitoring of HTGC changes during chemotherapy and for the detection of chemotherapy‐associated steatosis. Six of 26 patients developed steatosis during chemotherapy. Lipid changes were observable at 6 weeks. Copyright © 2012 John Wiley & Sons, Ltd. 相似文献
129.
130.
Liver stiffness measurement predicts high‐grade post‐hepatectomy liver failure: A prospective cohort study 下载免费PDF全文